Onodera Makoto, Fujino Yasuhisa, Inoue Yoshihiro, Endo Shigeatsu, Fujita Yuji
Department of Critical Care Medicine, Iwate Medical University School of Medicine.
Chudoku Kenkyu. 2008 Jan;21(1):75-81.
Case 1 was a 59-year-old female who had been taking distigmine bromide 20 mg/day for 2 years. She had concurrently developed pneumonia and was admitted to the hospital. Her pupil diameter was 1.0 mm, serum ChE value was decreased at 25 IU/L. Case 2 was a 72-year-old male who had been taking distigmine bromide 15 mg/day for 8 months. He was transported to the hospital with a chief complaint of dyspnea. His pupil diameter was 2.0 mm, serum ChE value was decreased at 75 IU/L, and he had concurrent pyothorax. Case 3 was a 74-year-old male who had been taking distigmine bromide 10 mg/day for 4 years. He was transported to the hospital with a chief complaint of disturbance of consciousness. His pupil diameter was 2.0 mm, and serum ChE value was decreased at 55 IU/L. He had concurrent aspiration pneumonia. In Case 1, the distigmine bromide concentration was elevated at 13.2 ng/mL at admission. However, it decreased from the following day. The two other patients had low concentrations of distigmine bromide. In all patients, ChE levels recovered after discontinuing distigmine bromide, and respiratory conditions also improved. Distigmine bromide was no longer detected in blood before ChE levels recovered.
病例1是一名59岁女性,服用溴化双斯的明20毫克/天,持续2年。她同时并发肺炎并入院治疗。其瞳孔直径为1.0毫米,血清胆碱酯酶(ChE)值降至25国际单位/升。病例2是一名72岁男性,服用溴化双斯的明15毫克/天,持续8个月。他因呼吸困难为主诉被送往医院。其瞳孔直径为2.0毫米,血清ChE值降至75国际单位/升,且并发脓胸。病例3是一名74岁男性,服用溴化双斯的明10毫克/天,持续4年。他因意识障碍为主诉被送往医院。其瞳孔直径为2.0毫米,血清ChE值降至55国际单位/升。他并发吸入性肺炎。在病例1中,入院时溴化双斯的明浓度升高至13.2纳克/毫升。然而,从第二天起浓度下降。其他两名患者的溴化双斯的明浓度较低。在所有患者中,停用溴化双斯的明后ChE水平恢复,呼吸状况也有所改善。在ChE水平恢复之前,血液中不再检测到溴化双斯的明。